Gene-diet-related factors of hyperglycaemia in postmenopausal women

Journal of Applied Genetics
Bogna Grygiel-GórniakJerzy Nowak

Abstract

As ageing and increased body fat are the signs of insulin resistance, we have studied whether the presence of Pro12Ala and C1431T of peroxisome proliferator-activated receptor gamma 2 gene and Trp64Arg of beta 3-adrenergic receptor gene may predispose to the hyperglycaemia development in postmenopausal women, who have never undergone hypoglycaemic treatment. The distributions of selected allele and genotype frequencies were determined by the PCR-RFLP method in normo- and hyperglycaemic, who have never been diagnosed and treated for diabetes mellitus were measured. The amount of body fat and lean body mass (LBM) were assessed by the bioimpedance method and nutritional habits by 7-day dietary recall. There were no differences between the distribution of genotypes and the allele frequencies of the Pro12Ala, C1431T and Trp64Arg polymorphisms in normo- and hyperglycaemic women. Hyperglycaemic women were characterized by visceral obesity, hypertension, higher serum insulin and triglycerides, higher intake of fat and lower consumption of complex carbohydrates and B vitamins. Normoglycaemic women with Pro12Pro polymorphism acquired higher energy from dietary fat (p < 0.0276) and lower energy from carbohydrates (p < 0.0480) than normogl...Continue Reading

References

Jan 23, 1998·Nutrition·M J Glade
Oct 4, 2000·Nature Genetics·D AltshulerL Kruglyak
Feb 24, 2001·Diabetes, Obesity & Metabolism·A M Oeveren van-DybiczI Vermes
Nov 6, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·M T Agulló-OrtuñoP Martínez
Apr 26, 2003·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Jul 1, 1957·The American Journal of Clinical Nutrition·B F CHOW, H H STONE
Aug 26, 2004·JAMA : the Journal of the American Medical Association·Matthias B SchulzeFrank B Hu
Sep 28, 2004·The American Journal of Clinical Nutrition·Sunmi YooGerald S Berenson
Dec 14, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·R WeitgasserB Paulweber
Aug 7, 2008·Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition·Rosane Ness-Abramof, Caroline M Apovian
Nov 10, 2010·Diabetic Medicine : a Journal of the British Diabetic Association·J S W LeeJ Woo
Feb 2, 2011·The Medical Clinics of North America·Martin Buysschaert, Michael Bergman
Apr 13, 2011·Diabetes Research and Clinical Practice·Li JianboWang Hongxing
Aug 2, 2011·Diabetes Research and Clinical Practice·Bahram Pourghassem GargariAkbar Aliasgharzadeh
Jan 6, 2012·Journal of the American Board of Family Medicine : JABFM·Robert E PostKit N Simpson
Sep 12, 2012·Archives of Medical Research·Blanca Patricia Lazalde-RamosGuillermo Moises Zúñiga-González
Feb 20, 2014·Diabetes·Siyu ChenChang Liu
Sep 2, 2016·Journal of Biosciences·Bogna Grygiel-GorniakJerzy Nowak

❮ Previous
Next ❯

Software Mentioned

Systoli
StatSoft

Related Concepts

Related Feeds

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.